Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
WADA status BPC-157 BPC-157 has no approval from any governmental regulatory health authority for human therapeutic use, and as such falls under WADA category S0 (Non-Approved Substances), prohibited at all times (ref
Dosing: - Frequency: It is administered via subcutaneous injection once weekly
The reclassification is a significant win for patient safety and access
Can be diluted in water or mixed with your favourite drink
If youre looking for the most effective medication for weight loss, youve likely heard of Tirzepatide and Semaglutide, two of the leading prescription treatments for obesity and metabolic health
The new form could increase interest and, therefore, pressure to cover, but in many ways, the financial dynamics remain similar to injectables
US$ 26.06
US$ 21.79
US$ 20.64
US$ 22.65
US$ 28.21
